What causes Erythromelalgia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What Causes Erythromelalgia?

Erythromelalgia has three main causes: genetic mutations in sodium channels (primary/inherited form), myeloproliferative disorders like polycythemia vera and essential thrombocythemia (secondary form), and idiopathic small fiber neuropathy (sporadic primary form). 1

Primary (Inherited) Erythromelalgia

Genetic mutations account for approximately 5% of cases with a family history, typically following autosomal dominant inheritance patterns. 1

  • SCN9A gene mutations are the primary genetic cause, encoding the Nav1.7 sodium channel found in sympathetic ganglia and pain-sensing neurons in dorsal root ganglia. 1
  • These are gain-of-function mutations that cause sodium channels to open more easily and remain open longer, leading to excessive and prolonged neuronal firing that explains the severe burning pain during episodes. 1, 2
  • The mutations also cause hypoexcitability of sympathetic neurons, contributing to the vascular dysregulation. 1
  • Non-SCN9A genetic variants exist - some families with inherited erythromelalgia show no SCN9A mutations, indicating other genes may be involved. 1, 2

Secondary Erythromelalgia

Myeloproliferative disorders are the most common identifiable cause of secondary erythromelalgia, present in approximately 5% of all cases. 1, 2

  • Polycythemia vera and essential thrombocythemia are the primary myeloproliferative disorders associated with erythromelalgia, with an estimated 3% incidence in polycythemia vera patients. 1, 2
  • The mechanism involves platelet-mediated endothelial injury causing inflammation and transient thrombotic occlusion by platelet aggregates, with thromboxane-mediated platelet activation playing a key pathogenetic role. 2
  • Chronic myelogenous leukemia has also been documented as a cause. 3
  • Importantly, erythromelalgia symptoms often precede the diagnosis of myeloproliferative disease by a median of 2.5 years, making periodic blood count monitoring essential in all patients. 3, 4

Other secondary causes include:

  • Autoimmune conditions such as systemic lupus erythematosus and other rheumatic diseases. 2, 5
  • Medications including calcium channel blockers, bromocriptine, ergot derivatives, and pseudoephedrine. 2, 5, 6
  • Viral infections. 5

Idiopathic Primary Erythromelalgia with Neuropathy

Small fiber neuropathy is strongly associated with erythromelalgia, found in approximately 90% of patients on thermoregulatory sweat testing. 1, 2

  • Large fiber neuropathy is detected on electromyography and nerve conduction studies in almost 50% of patients. 1, 2
  • The relationship between neuropathy and erythromelalgia is bidirectional and unclear - small fiber neuropathy may precipitate erythromelalgia, or the underlying disease process may cause both conditions simultaneously. 1, 2
  • Skin biopsies typically show decreased epidermal nerve fiber density in only a minority of cases, making them less useful diagnostically. 1

Pathophysiologic Mechanism

Vasodilation of thermoregulatory arteriovenous anastomoses is likely a key factor in the pathophysiology, with endogenous temperature control playing a central role. 1

Critical Clinical Pitfall

Any adult presenting with erythromelalgia requires periodic blood count monitoring because myeloproliferative disorders frequently manifest years after erythromelalgia symptoms begin. 3, 4 An abnormal hemoglobin level, white blood cell count, platelet count, or presence of immature cells should prompt immediate hematologic evaluation, as these findings are not seen in idiopathic erythromelalgia. 3, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Erythromelalgia Causes and Mechanisms

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Erythromelalgia and myeloproliferative disorders.

Archives of internal medicine, 1989

Research

[Erythromelalgia: Diagnosis and therapeutic approach].

La Revue de medecine interne, 2017

Research

A novel cause of erythromelalgia due to pseudoephedrine.

Oxford medical case reports, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.